WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016087810) A PLANT EXTRACT AND COMPOUNDS FOR USE IN WOUND HEALING
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/087810    International Application No.:    PCT/GB2015/000312
Publication Date: 09.06.2016 International Filing Date: 30.11.2015
IPC:
A61K 36/537 (2006.01), A61P 17/02 (2006.01), A61P 5/46 (2006.01)
Applicants: PHYNOVA LIMITED [GB/GB]; 16 Blenheim Office Park Long Hanborough OX29 8LN (GB)
Inventors: GALLAGHER, Andrew B.; (GB).
HARTMANN, Rolf W.; (DE).
ENGEL, Matthias; (DE).
KOCH, Axel; (DE).
VAN KOPPEN, Chris J.; (DE)
Agent: EQUIPPED 4 (IP) LIMITED; 47 Hamilton Square Birkenhead CH41 5AR (GB)
Priority Data:
1421479.5 03.12.2014 GB
Title (EN) A PLANT EXTRACT AND COMPOUNDS FOR USE IN WOUND HEALING
(FR) EXTRAIT DE PLANTE ET COMPOSÉS POUR UTILISATION DANS LA CICATRISATION DES PLAIES
Abstract: front page image
(EN)This invention relates to the use of a plant extract, derived from a Salvia spp, comprising one or more tanshinone compounds, or said one or more tanshinone compounds, in the treatment of wounds, particularly chronic wounds, or other conditions benefiting from inhibition of Cortisol production, particularly Cushing's syndrome. Preferred tanshinone compounds include, but are not limited to, dihydrotanshinone (particularly 15,16- dihydrotanshinone (CAS No. 87205-99-0) ) and Tanshinone I.
(FR)La présente invention concerne l'utilisation d'un extrait de plante, dérivé de Salvia spp, comprenant un ou plusieurs composés de tanshinone, ou lesdits un ou plusieurs composés de tanshinone, dans le traitement de plaies, en particulier de plaies chroniques, ou d'autres affections dans lesquelles l'inhibition de la production de cortisol a des effets bénéfiques, en particulier le syndrome de Cushing. Des composés de tanshinone préférés comprennent, mais ne sont pas limités à, la dihydrotanshinone (en particulier la 15,16-dihydrotanshinone (CAS n° CAS87205 -99 -0)) et la tanshinone I.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)